Informed consent as documented by signature (see informed consent form)
Primary ITP according to the definition of Rodeghiero et al. (52) and a platelet count of <30x109/l
Age range: 18-45 years
Previously treated patients, with failure or intolerance to first-line therapy, or relapse after first-line therapy, i.e. corticosteroids, intravenous immunoglobulin (IVIG), or anti-D immunoglobulins

NCT02760251_inc_T2
Condition
Primary ITP
NCT02760251_inc_T3
Measurement
definition of Rodeghiero
NCT02760251_inc_T4
Measurement
platelet count
NCT02760251_inc_T5
Value
<30x109/l
NCT02760251_inc_T6
Scope
definition of Rodeghiero et al. (52) and a platelet count of <30x109/l
NCT02760251_inc_T7
Person
Age
NCT02760251_inc_T8
Value
18-45 years
NCT02760251_inc_T9
Observation
Previously treated
NCT02760251_inc_T10
Procedure
first-line therapy
NCT02760251_inc_T11
Qualifier
failure
NCT02760251_inc_T12
Qualifier
intolerance
NCT02760251_inc_T13
Condition
relapse
NCT02760251_inc_T14
Temporal
after first-line therapy
NCT02760251_inc_T15
Reference_point
first-line therapy
NCT02760251_inc_T16
Procedure
first-line therapy
NCT02760251_inc_T17
Drug
corticosteroids
NCT02760251_inc_T18
Drug
intravenous immunoglobulin
NCT02760251_inc_T19
Drug
anti-D immunoglobulins
NCT02760251_inc_T20
Drug
IVIG